- en: <!--yml
  prefs: []
  type: TYPE_NORMAL
- en: 'category: 未分类'
  prefs: []
  type: TYPE_NORMAL
- en: 'date: 2024-05-18 18:31:13'
  prefs: []
  type: TYPE_NORMAL
- en: -->
  prefs: []
  type: TYPE_NORMAL
- en: 'VIX and More: Biotech on a Tear'
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
- en: 来源：[http://vixandmore.blogspot.com/2008/07/biotech-on-tear.html#0001-01-01](http://vixandmore.blogspot.com/2008/07/biotech-on-tear.html#0001-01-01)
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
- en: While most sectors have been faltering for the past month or two, [biotechnology](http://vixandmore.blogspot.com/search/label/biotech)
    has been an exceptional performer, with the top biotech ETF, [IBB](http://vixandmore.blogspot.com/search/label/IBB),
    now more than 15% above its June low, as the chart below shows.
  prefs: []
  type: TYPE_NORMAL
- en: I last profiled biotech on May 1^(st) in [Time for Biotech to Turn Around?](http://vixandmore.blogspot.com/2008/05/time-for-biotech-to-turn-around.html)  In
    retrospect, May and June were excellent months to get long biotech, even as the
    broad markets headed south.
  prefs: []
  type: TYPE_NORMAL
- en: 'Of IBBs top ten holdings, five of the ten are currently at or just below their
    52 week highs, including:'
  prefs: []
  type: TYPE_NORMAL
- en: Amgen ([AMGN](http://finance.google.com/finance?q=amgn)) – making another new
    52 week high today
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: Illumina ([ILMN](http://finance.google.com/finance?q=ilmn)) – made a new 52
    week high yesterday
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: Celgene ([CELG](http://finance.google.com/finance?q=celg)) – just 1.6% below
    its 52 week high
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: Gilead Sciences ([GILD](http://finance.google.com/finance?q=gild)) – 5.7% below
    its 52 week high, but up about 40% for the year
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: Genzyme ([GENZ](http://finance.google.com/finance?q=genz)) – 7.1% below the
    52 week high, set back in January
  prefs:
  - PREF_UL
  type: TYPE_NORMAL
- en: 'Of course, there are many more success stories among some of the smaller cap
    biotechnology companies.  So while the markets drift sideways and we wait to see
    if traditional technology stocks can provide leadership, this might be a good
    time to stock up on one of the few strong sectors: biotechnology.'
  prefs: []
  type: TYPE_NORMAL
